THURSDAY, Feb. 6, 2025 (HealthDay News) — Set, hut! Super Bowl Sunday is almost here. But it’s not just about big plays and bad calls, it’s also a sodium tsunami. On average, foods advertised during NFL games contain 40% of the daily recommended sodium intake, researchers reported recently in JAMAContinue Reading

WEDNESDAY, Feb. 5, 2025 (HealthDay News) — “Yo-yo” dieting — repeatedly losing and gaining weight — can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics with greater weight fluctuations experienced a 40% decline in their kidneys’ ability to filter toxins fromContinue Reading

WEDNESDAY, Jan. 8, 2025 (HealthDay News) — Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been approved for that purpose. A new evidence review published in the Annals of Internal Medicine shows that the widely-known drugs tirzepatide (Zepbound) and semaglutideContinue Reading

THURSDAY, Jan. 2, 2024 (HealthDay News) — Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways toContinue Reading

MONDAY, Dec. 23, 2024 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicinesContinue Reading